China NMPA Inspection - National Medical Products Administration - November 24, 2021

This document functions as an official announcement from the Anhui Provincial Drug Administration Fifth Branch regarding the availability of cosmetics production inspection information for the period spanning July to December 2021. Published on November 24, 2021, the announcement indicates a regulatory oversight framework involving the National Medical Products Administration (NMPA), along with digital tools such as the China Drug Administration App and the Cosmetics Supervision App. The text itself is an announcement *about* forthcoming inspection details rather than a specific inspection report. Consequently, it does not contain the names of companies inspected, detailed main violations or issues discovered, or any specific required actions for non-compliance. Instead, it serves to inform the public about the upcoming release of broader inspection data compiled by the Anhui provincial authority under the NMPA's umbrella.